首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Two cases of multidrug-resistant Nocardia farcinica infection in immunosuppressed patients and implications for empiric therapy.
【24h】

Two cases of multidrug-resistant Nocardia farcinica infection in immunosuppressed patients and implications for empiric therapy.

机译:2例免疫抑制患者的多药耐药诺卡氏菌诺卡氏菌感染及其对经验治疗的意义。

获取原文
获取原文并翻译 | 示例
           

摘要

Presented here are two cases of multidrug-resistant Nocardia farcinica infection that occurred in immunocompromised patients. One of the patients developed the infection despite being on trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis jiroveci. These cases demonstrate the propensity of Nocardia spp. to cause disseminated disease and to develop resistance to multiple antimicrobial agents used in the initial treatment of serious Nocardia infection. These factors lead to the conclusion that empiric monotherapy with trimethoprim/sulfamethoxazole may not be sufficient. Treatment with a combination regimen of imipenem and amikacin may be a more promising initial therapy.
机译:这里介绍了两例免疫受损患者发生的多药耐药诺卡氏菌诺卡氏菌感染。尽管正在使用甲氧苄啶/磺胺甲基异恶唑预防罗氏肺孢子虫,但其中一名患者仍感染。这些情况证明了诺卡氏菌的倾向。引起传播的疾病并发展对严重诺卡氏菌感染的初始治疗中使用的多种抗菌药物的耐药性。这些因素得出的结论是,甲氧苄啶/磺胺甲恶唑的经验性单药治疗可能不够。亚胺培南和丁胺卡那霉素的联合治疗可能是一个更有希望的初始治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号